Shingles during pregnancy is generally not dangerous for the baby. Unlike a first-time chickenpox infection, which can cause birth defects and serious complications, a shingles outbreak represents the reactivation of a virus a woman’s body has already fought once before, and her existing immunity keeps the fetus well protected. The real concern with shingles in pregnancy is less about the baby and more about managing the mother’s pain safely, which is a genuinely tricky clinical problem worth understanding.
Why Shingles and Chickenpox Are Not the Same Threat
Shingles and chickenpox are caused by the same virus, varicella-zoster virus (VZV), but they represent fundamentally different events in the body. Chickenpox is the initial infection, and when a pregnant woman catches it for the first time, the virus circulates freely through her bloodstream and can cross the placenta to reach the fetus. That primary infection carries real risks: a condition called congenital varicella syndrome can cause skin scarring, limb abnormalities, eye problems, and neurological damage in the baby, particularly when the mother is infected in the first half of pregnancy.
Shingles, on the other hand, is a reactivation of virus that has been lying dormant in nerve cells, sometimes for decades. Because the woman was previously infected (usually as a child), her immune system already has antibodies against VZV. Those antibodies prevent the virus from entering the bloodstream in significant amounts. The reactivation stays localized to a patch of skin along a single nerve pathway, which is why shingles typically appears as a painful band of blisters on one side of the body rather than spreading everywhere. That localized nature is the key reason shingles does not pose the same fetal risk as chickenpox. A review in Reproductive Toxicology noted that herpes zoster has not been documented to cause complications in pregnancy unless the infection becomes disseminated, a rare situation where the rash spreads beyond its usual dermatome.1Reproductive Toxicology. Chickenpox in pregnancy: Revisited
A 2025 review in Pathogens confirmed that when VZV reactivates during pregnancy, it usually does not cause harm to the fetus or lead to any birth defects.2PubMed Central. Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach This is the consistent message across the medical literature: the baby is not the one at risk during a shingles episode.
How Rare Shingles in Pregnancy Actually Is
Shingles during pregnancy is uncommon. Estimates place its occurrence at roughly one in every 20,000 pregnancies.3PubMed Central. Herpes Zoster in Pregnancy: Clinical Outcomes and Treatment Patterns from a Multicenter Retrospective Cohort There is a biological reason for this low number. Shingles tends to strike when the immune system is weakened by age, stress, or disease, and while pregnancy does modestly alter immune function, it typically does so in ways that shift immune balance rather than deeply suppressing it. Most pregnant women are young enough that their immune surveillance keeps VZV dormant without trouble.
The rarity creates its own kind of problem, though. Because obstetricians see so few cases, there is limited large-scale research compared to what exists for chickenpox in pregnancy. Much of the evidence comes from case reports and small cohorts rather than randomized trials. A multicenter retrospective study published in the Journal of Pain Research tracked 72 pregnant women with shingles through delivery and found no adverse outcomes related to the infection itself or its treatment in either the mothers or their infants.3PubMed Central. Herpes Zoster in Pregnancy: Clinical Outcomes and Treatment Patterns from a Multicenter Retrospective Cohort That study is reassuring, but 72 women is a small sample. The consistent absence of reported fetal harm across decades of case literature, rather than any single definitive trial, is what gives clinicians confidence that shingles is safe for the baby.
The Mother Is the One Who Suffers
While the baby faces little danger, shingles can be genuinely miserable for the pregnant woman. The hallmark of shingles is neuropathic pain, which can range from mild burning or tingling to severe, stabbing pain along the affected nerve. Pregnancy complicates this because many of the medications typically used for nerve pain are either unsafe or poorly studied in pregnant women. Drugs like gabapentin and pregabalin, which are commonly prescribed for shingles-related nerve pain outside of pregnancy, carry enough concern about fetal effects that they are generally avoided.
That same multicenter cohort study documented a case that illustrates the worst-case maternal scenario. A 41-year-old woman with extensive herpetic lesions and severe pain ultimately chose to have an induced abortion so she could receive unrestricted treatment. Even after the pregnancy ended, she developed postherpetic neuralgia, the long-lasting nerve pain that sometimes follows shingles, and continued to require long-term pain medication.4PubMed Central. Herpes Zoster in Pregnancy: Clinical Outcomes and Treatment Patterns from a Multicenter Retrospective Cohort – Section: Results This is an extreme case involving an older mother with unusually widespread lesions, not a typical outcome, but it underscores that the maternal burden of shingles in pregnancy can be significant even though the fetal risk is low.
The review in Pathogens echoed this framing: while VZV reactivation usually does not harm the fetus, it may increase maternal morbidity due to the herpes zoster episode and its complications.2PubMed Central. Varicella Zoster Virus Infection and Pregnancy: An Optimal Management Approach
How Shingles Is Treated During Pregnancy
The standard treatment for shingles in pregnancy is oral acyclovir, an antiviral drug that has been used in pregnant women for decades and has a well-established safety profile.5PubMed. Management of herpes zoster (shingles) during pregnancy Acyclovir works by interfering with the virus’s ability to replicate, which shortens the duration of the rash and reduces the severity of pain if started early. Ideally, treatment begins within 72 hours of the rash appearing.
Managing the pain component is trickier. Acetaminophen (paracetamol) is the go-to for mild to moderate pain. For more severe cases, clinicians have to get creative. A case report published in the Chinese Medical Journal described a pregnant patient at 26 weeks of gestation who had acute shingles with significant nerve pain. She was treated with oral acyclovir combined with an ultrasound-guided nerve block targeting the specific thoracic nerve involved. Both mother and baby did well, with no adverse effects from the procedure.6PubMed Central. Safe drug treatment and procedure for herpes zoster in pregnancy: a case report Nerve blocks offer targeted relief without systemic drug exposure to the fetus, making them an appealing option when pain is severe and concentrated along a single nerve path.
The practical takeaway is that shingles in pregnancy is treatable. It is not a situation where a woman has to simply endure untreated pain for the sake of the baby. The antiviral side is straightforward; the pain management side requires more thought but has workable solutions.
How Maternal Antibodies Protect the Baby
The reason shingles poses so little fetal risk comes down to antibodies. A woman who has had chickenpox in the past carries VZV-specific antibodies, and these cross the placenta during pregnancy. This transfer of immunity is one of the ways newborns arrive in the world with some built-in protection against infections their mothers have encountered.
A study of 350 mother-newborn pairs examined VZV antibody levels at delivery. About 15% of mothers tested positive for varicella antibodies at protective levels, and roughly 17% of their babies also tested positive, confirming that the antibodies do cross the placenta effectively.7PubMed. Mother-to-Child Transfer of Reactivated Varicella-Zoster Virus DNA and Varicella-Zoster IgG in Pregnancy These numbers may seem low, but the study used a specific antibody threshold for “positive” status and also identified a borderline category. The broader point holds: maternal antibodies transfer to the fetus and provide a layer of protection that is absent during a first chickenpox infection, when the mother has no pre-existing antibodies to share.
This passive immunity also explains why even if small amounts of viral DNA enter the mother’s bloodstream during a shingles reactivation, the circulating antibodies neutralize the virus before it can reach the placenta in quantities sufficient to cause damage. The system is not foolproof in theory, but in practice it has proven remarkably effective. Documented cases of fetal harm from maternal shingles are essentially absent from the medical literature.
The Situation That Actually Is Dangerous
The scenario that deserves genuine alarm is not shingles during pregnancy but rather a first chickenpox infection near the time of delivery. If a mother develops chickenpox from five days before birth to two days after, the newborn can be exposed to the virus at a moment when the baby has not yet received enough maternal antibodies to mount a defense. Neonatal varicella in this setting can be severe and, historically, carried a significant fatality rate before the availability of treatment.
For exposed newborns, varicella-zoster immune globulin (VZIG) is the frontline preventive measure. A review of five studies found that giving VZIG to VZV-exposed newborns prevented roughly half of symptomatic cases and reduced the severity of infection in the rest. The most severe disease in those studies occurred in babies born within five days of the mother’s rash appearing.8PubMed Central. Management of varicella in neonates and infants – Section: Immune globulins An expanded-access program also studied a specific VZIG product (VARIZIG) in high-risk infants to assess safety and outcomes.9PubMed Central. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program – Section: METHODS
This distinction between peripartum chickenpox and shingles at any point in pregnancy is the single most important thing to understand. A pregnant woman who already carries VZV antibodies and has a shingles flare is in a categorically different position from a woman encountering the virus for the first time at 39 weeks. The two situations share a virus but almost nothing else in terms of risk to the baby.
Breastfeeding After a Shingles Episode
Women who have shingles around the time of delivery or in the postpartum period often worry about whether they can safely breastfeed. The answer is usually yes, with one practical caveat: if the shingles lesions are located on or near the breast, direct breastfeeding from the affected side should be avoided until the lesions have crusted over, because contact with open blisters could expose the baby to the virus. Pumping and discarding milk from the affected breast while nursing from the other side is a common workaround during the active phase.
A narrative review on maternal viral infections and breastfeeding noted that VZV is a contraindication to breastfeeding only in specific high-risk circumstances, not as a blanket rule.10Journal of Pediatric and Neonatal Individualized Medicine. How and when maternal viral infections can be a contraindication to breastfeeding: a narrative review For shingles on the torso, back, or face, with no lesions near the breast area, breastfeeding can continue normally as long as the lesions are covered. The antibodies in breast milk may even provide additional passive protection to the newborn.
Who Gets Confused and Why
The most common source of confusion is the failure to distinguish between shingles and chickenpox in pregnancy. Over 90% of women of childbearing age are already immune to VZV, typically from childhood infection or vaccination. That means primary varicella (chickenpox) in pregnancy is itself rare, affecting roughly three in every 1,000 pregnancies. When it does occur, the risk to the fetus is real but still lower than many people assume. Congenital varicella syndrome occurs in about 1-2% of fetuses exposed to maternal chickenpox in the first 20 weeks.
Shingles, as discussed, carries virtually no documented fetal risk. Yet both conditions produce a recognizable rash caused by the same virus, and the internet often lumps them together under “varicella-zoster virus in pregnancy” without adequately separating the two clinical scenarios. If you are pregnant, have a history of chickenpox or vaccination, and develop a painful unilateral rash that your doctor identifies as shingles, the evidence strongly suggests your baby will be fine. Your own comfort and pain management are the primary clinical concerns.
Why You Cannot Get the Shingles Vaccine While Pregnant
The current shingles vaccine (Shingrix) is not recommended during pregnancy, mainly because it has not been studied in pregnant women and therefore lacks safety data for that population. Shingrix is a recombinant (non-live) vaccine, which in principle should carry less theoretical risk than the older live-virus vaccine (Zostavax, no longer available in many countries), but “not studied” is not the same as “known to be safe.” Women who are planning a pregnancy and fall into a higher-risk category for shingles, such as those who are immunocompromised, should discuss vaccination timing with their doctor beforehand. For most women of typical childbearing age, the shingles vaccine is not routinely recommended anyway, since it is primarily approved for adults 50 and older.
If you have had shingles during a pregnancy and are concerned about recurrence in future pregnancies, getting vaccinated in between pregnancies is an option worth discussing. Recurrent shingles is uncommon in healthy individuals, but it does happen, and vaccination substantially reduces the risk of another episode.
When to Worry and When Not To
The one scenario involving shingles in pregnancy that does warrant urgent medical attention is disseminated herpes zoster, where the rash spreads beyond a single dermatome to multiple areas of the body or involves internal organs. This is rare and almost exclusively seen in people with significantly weakened immune systems, such as those undergoing chemotherapy or living with untreated HIV. In that situation, the virus can enter the bloodstream in large amounts, and the theoretical risk to the fetus rises. Disseminated zoster in pregnancy is treated aggressively with intravenous antiviral medication and close monitoring.
For the vast majority of pregnant women who develop a typical, localized shingles rash, the clinical path is straightforward: start oral acyclovir promptly, manage pain with pregnancy-safe approaches, keep the rash covered, and inform your obstetric provider so they can note it in your chart. The baby does not need any special monitoring or testing because of the shingles episode itself. The anxiety many women feel when they see the words “varicella-zoster virus” and “pregnancy” in the same sentence is understandable, but the evidence accumulated over decades consistently points in the same direction: localized shingles in a previously immune woman does not harm her baby.